Texas Bank & Trust’s AstraZeneca AZN Stock Holding History

Texas Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,534	Closed	-$1.75M	–	177
2025 Q4	$1.75M	Buy	9,534 +420	+5%	+$73.7K	0.64%	36
2025 Q3	$1.4M	Buy	9,114 +395	+5%	+$59.8K	0.53%	46
2025 Q2	$1.22M	Buy	8,719 +437	+5%	+$61.2K	0.48%	54
2025 Q1	$1.22M	Buy	8,282 +271	+3%	+$39.2K	0.52%	50
2024 Q4	$1.05M	Buy	+8,011	New	+$1.12M	0.43%	66

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Texas Bank & Trust's AZN Position: Q1 2026 in Review

Texas Bank & Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 9,534 shares — an estimated $1.75M sold.

Texas Bank & Trust first reported a position in AZN in Q4 2024 and held it in 5 quarters. The position peaked at $1.75M in Q4 2025. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Texas Bank & Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Texas Bank & Trust sold 9,534 AstraZeneca shares in Q1 2026, an estimated $1.75M.
Texas Bank & Trust first reported a position in AstraZeneca in Q4 2024 and held it in 5 quarters.
Texas Bank & Trust's AstraZeneca position peaked at $1.75M in Q4 2025.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.